Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial

REFERENCES

• Blackwelder , W. C. 1982 . Proving the null hypothesis in clinical trials . Control. Clin. Trials , 3 : 345 – 353 .
   PubMedGoogle Scholar
• Blackwelder , W. C. 2002 . Commentary-showing a treatment is good because it is not bad: when does “non-inferiority” imply effectiveness? . Control. Clin. Trials , 23 : 52 – 54 .
   PubMedGoogle Scholar
• Bucher , H. C. , Guyatt , G. H. Griffith , L. E. 1997 . The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials . J. Clin. Epidemiol. , 50 : 683 – 691 .
   PubMed Web of Science ®Google Scholar
• in press .
   Google Scholar
• Durrleman , S. and Simon , R. 1990 . Planning and monitoring of equivalence studies . Biometrics , 46 : 329 – 336 .
   PubMed Web of Science ®Google Scholar
• Ebbutt , A. F. and Frith , L. 1998 . Practical issues in equivalence trials . Stat. Med. , 17 : 1691 – 1701 .
   PubMed Web of Science ®Google Scholar
• 1992 . Guidance on Statistical Procedure for Bioequivalence Studies Using Two-Treatment Crossover Design Rockville, MD : Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration .
   Google Scholar
• Fisher , L. D. 1998 . Active control trials: what about a placebo? A method illustrated with clopidogrel, aspirin and placebo . J. Am. Coll. Cardiol. , 31 : 49A (abstract)
   Google Scholar
• Fisher , L. D. , Gent , M. and Bηller , H. R. 2001 . Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo' . Am. Heart J. , 141 : 26 – 32 .
   PubMed Web of Science ®Google Scholar
• Fleming , T. R. 1987 . Treatment evaluation in active control studies . Cancer Treat. Rep. , 71 ( 11 ) : 1061 – 1065 .
   PubMedGoogle Scholar
• Fleming , T. R. 1990 . Evaluation of active control trials in AIDS . J. Acquir. Immune. Defic. Syndr. , 3 ( Suppl 2 ) : S82 – S87 .
   PubMed Web of Science ®Google Scholar
• Fleming , T. R. 2000 . Design and interpretation of equivalence trials . Am. Heart J. , 139 : S171 – S176 .
   PubMed Web of Science ®Google Scholar
• Hasselblad , V. and Kong , D. F. 2001 . Statistical methods for comparison to placebo in active-control trials . Drug Inf. J. , 35 : 435 – 449 .
   Web of Science ®Google Scholar
• Hauck , W. W. and Anderson , S. 1999 . Some issues in the design and analysis of equivalence trials . Drug Inf. J. , 33 : 109 – 118 .
   Web of Science ®Google Scholar
• Holmgren , E. B. 1999 . Establishing equivalence by showing that a prespecified percentage of the effect of the active control over placebo is maintained . J. Biopharm. Stat. , 9 ( 4 ) : 651 – 659 .
   PubMedGoogle Scholar
• Hung , H. M. J. , Wang , S. J. , Tsong , Y. , Lawrence , J. and O'Neill , R. T. 2001 . “ Some fundamental issues for non-inferiority testing in active controlled trials ” . In Proceedings of Biopharmaceutical Section of American Statistical Association
   Google Scholar
• 1999 . Statistical principles for clinical trials, international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use . Stat. Med. , 18 : 1905 – 1942 .
   PubMed Web of Science ®Google Scholar
• in press .
   Google Scholar
• Jones , B. , Jarvis , P. , Lewis , J. A. and Ebbutt , A. F. 1996 . Trials to assess equivalence: the importance of rigorous methods . Br. Med. J. , 313 : 36 – 39 .
   PubMed Web of Science ®Google Scholar
• Li , N. , Rothman , M. , Chen , G. and Chi , G. 2001 . “ Application of non-inferiority analysis in oncology NDA ” . In Proceedings of Biopharmaceutical Section of American Statistical Association
   Google Scholar
• Mau , J. 1988 . A statistical assessment of clinical equivalence . Stat. Med. , 7 : 1267 – 1277 .
   PubMed Web of Science ®Google Scholar
• Pledger , G. and Hall , D. B. 1990 . “ Active control equivalence studies: do they address the efficacy issue? ” . In Statistical Issues in Drug Research and Development 226 – 238 . New York : Marcel Dekker .
   Google Scholar
• Rohmel , J. 1998 . Therapeutic equivalence investigations: statistical considerations . Stat. Med. , 17 : 1703 – 1714 .
   PubMed Web of Science ®Google Scholar
• Rothman , M. , Li , N. , Chen , G. , Chi , G. and Tsou , H. H. 2001 . “ Non-inferiority methods for mortality trials ” . In Proceedings of Biopharmaceutical Section of American Statistical Association
   Google Scholar
• Schuirmann , D. J. 1987 . A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability . J. Pharm. Biopharm. , 15 : 657 – 680 .
   PubMedGoogle Scholar
• Siegel , J. P. 2000 . Equivalence and noninferiority trials . Am. Heart J. , 139 : S166 – S170 .
   PubMed Web of Science ®Google Scholar
• Snappin , S. 2001 . “ Alternatives for discounting historical data in the analysis of non-inferiority trials ” . In International Chinese Statistical Association Bulletin 29 – 30 .
   Google Scholar
• Temple , R. 1983 . “ Difficulties in Evaluating Positive Control Trials ” . In Proceedings of the Biopharmaceutical Section, American Statistical Association 1 – 7 .
   Google Scholar
• Temple , R. 1996 . Problems in interpreting active control equivalence trials . Accountability Res. , 4 : 267 – 275 .
   PubMedGoogle Scholar
• Temple , R. and Ellenberg , S. S. 2000 . Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 1: ethical and scientific issues, Part 2: ethical and scientific issues . Ann. Intern. Med. , 133 : 455 – 463 .
   PubMed Web of Science ®Google Scholar
• Tsong , Y. , Higgins , K. , Wang , S. J. and Hung , H. M. J. 1999 . “ An overview of equivalence testing—CDER reviewers' perspective ” . In Proceedings of the Biopharmaceutical Section of American Statistical Association 214 – 219 .
   Google Scholar
• Tsong , Y. , Wang , S. J. , Hung , H. M. J. and Cui , L. 2001 . “ Objectives, designs and analysis of non-inferiority active controlled clinical trial ” . In Proceedings of Biopharmaceutical Section of American Statistical Association
   Google Scholar
• Wang , S. J. , Hung , H. M. J. and Tsong , Y. 2002 . Utility and pitfall of some statistical methods in active controlled clinical trials . Control. Clin. Trials , 23 : 15 – 28 .
   PubMedGoogle Scholar
• Wang , S. J. , Hung , H. M. J. , Tsong , Y. , Cui , L. and Nuri , W. A. 2001 . Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials . Stat. Med. , 20 : 1903 – 1912 .
   PubMed Web of Science ®Google Scholar
• Wiens , B. L. 2002 . Choosing an equivalence limit for noninferiority or equivalence studies . Control. Clin. Trials , 23 : 2 – 14 .
   PubMedGoogle Scholar
• Wittes , J. 2001 . “ Active-control trials: a linguistic problem ” . In International Statistical Association Bulletin 39 – 40 .
   Google Scholar